Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework
- PMID: 29907802
- PMCID: PMC6295277
- DOI: 10.1038/s41436-018-0028-2
Evaluating the role of public health in implementation of genomics-related recommendations: a case study of hereditary cancers using the CDC Science Impact Framework
Abstract
Public health plays an important role in ensuring access to interventions that can prevent disease, including the implementation of evidence-based genomic recommendations. We used the Centers for Disease Control and Prevention (CDC) Science Impact Framework to trace the impact of public health activities and partnerships on the implementation of the 2009 Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Lynch Syndrome screening recommendation and the 2005 and 2013 United States Preventive Services Task Force (USPSTF) BRCA1 and BRCA2 testing recommendations.The EGAPP and USPSTF recommendations have each been cited by >300 peer-reviewed publications. CDC funds selected states to build capacity to integrate these recommendations into public health programs, through education, policy, surveillance, and partnerships. Most state cancer control plans include genomics-related goals, objectives, or strategies. Since the EGAPP recommendation, major public and private payers now provide coverage for Lynch Syndrome screening for all newly diagnosed colorectal cancers. National guidelines and initiatives, including Healthy People 2020, included similar recommendations and cited the EGAPP and USPSTF recommendations. However, disparities in implementation based on race, ethnicity, and rural residence remain challenges. Public health achievements in promoting the evidence-based use of genomics for the prevention of hereditary cancers can inform future applications of genomics in public health.
Keywords: Science Impact Framework; evaluation; hereditary breast and ovarian cancer; Lynch syndrome; public health genomics.
Conflict of interest statement
None of the authors have a conflict of interest.
Figures

Similar articles
-
Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.Public Health Genomics. 2020;23(5-6):218-229. doi: 10.1159/000510336. Epub 2020 Sep 17. Public Health Genomics. 2020. PMID: 32942283 Free PMC article.
-
Implementing screening for Lynch syndrome among patients with newly diagnosed colorectal cancer: summary of a public health/clinical collaborative meeting.Genet Med. 2012 Jan;14(1):152-62. doi: 10.1038/gim.0b013e31823375ea. Epub 2011 Oct 27. Genet Med. 2012. PMID: 22237445 Free PMC article.
-
Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.Genet Med. 2009 Jan;11(1):35-41. doi: 10.1097/GIM.0b013e31818fa2ff. Genet Med. 2009. PMID: 19125126 Free PMC article.
-
The uptake of presymptomatic genetic testing in hereditary breast-ovarian cancer and Lynch syndrome: a systematic review of the literature and implications for clinical practice.Fam Cancer. 2019 Jan;18(1):127-135. doi: 10.1007/s10689-018-0089-z. Fam Cancer. 2019. PMID: 29846880
-
Novel Cancer Prevention Strategies in Individuals With Hereditary Cancer Syndromes: Focus on BRCA1, BRCA2, and Lynch Syndrome.Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e433576. doi: 10.1200/EDBK_433576. Am Soc Clin Oncol Educ Book. 2024. PMID: 38913968 Review.
Cited by
-
Public Interest in Population Genetic Screening for Cancer Risk.Front Genet. 2022 Jul 22;13:886640. doi: 10.3389/fgene.2022.886640. eCollection 2022. Front Genet. 2022. PMID: 35938028 Free PMC article.
-
Advancing health equity: A qualitative study assessing barriers and facilitators of implementing hereditary breast and ovarian cancer risk screening tools in community-based organizations.J Genet Couns. 2023 Oct;32(5):965-981. doi: 10.1002/jgc4.1705. Epub 2023 Apr 16. J Genet Couns. 2023. PMID: 37062905 Free PMC article.
-
The intersection of genomics and big data with public health: Opportunities for precision public health.PLoS Med. 2020 Oct 29;17(10):e1003373. doi: 10.1371/journal.pmed.1003373. eCollection 2020 Oct. PLoS Med. 2020. PMID: 33119581 Free PMC article.
-
Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature.Gynecol Oncol. 2023 Jun;173:106-113. doi: 10.1016/j.ygyno.2023.04.006. Epub 2023 Apr 26. Gynecol Oncol. 2023. PMID: 37116391 Free PMC article.
-
Adaptation and early implementation of the PREdiction model for gene mutations (PREMM5™) for lynch syndrome risk assessment in a diverse population.Fam Cancer. 2022 Apr;21(2):167-180. doi: 10.1007/s10689-021-00243-3. Epub 2021 Mar 23. Fam Cancer. 2022. PMID: 33754278 Free PMC article.
References
-
- Kuchenbaecker KB, Hopper JL, Barnes DR, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. JAMA. 2017;317(23):2402–2416. - PubMed
-
- Moyer VA, United States Preventive Services Task Force Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160(4):271–281. - PubMed
-
- Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med. 2009;11(1):35–41. - PMC - PubMed
-
- National Comprehensive Cancer Network. NCCN Guidelines Version 1.2017 Genetics/Familial High-Risk Assessment: Colon. Available at: https://www.nccn.org/professionals/physician_gls/pdf/genetics_colon.pdf. Accessed February 5, 2018.
-
- Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Hu L, Fu R. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: A systematic review to update the U.S. preventive services task force recommendation. Annals of Internal Medicine. 2014;160(4):255–266. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous